SKHHY (SKHHY) Stock Price & Analysis
SKHHY (SKHHY) rose 2.66% to USD 13.87 as of June 10, 2026 at 03:50 UTC, according to Nexqual real-time market data.
SKHHY last closed at USD 13.51; the session ranged USD 13.73–13.9 on volume of 22,997 shares. Market capitalization is $6.97B, with a 52-week range of USD 12.94–19.25 (PNK). Source: Nexqual, June 10, 2026 at 03:50 UTC.
Key Statistics (as of June 10, 2026 at 03:50 UTC)
| Price | USD 13.87 |
|---|---|
| Change | ▲ 2.66% (up) |
| Previous Close | USD 13.51 |
| Open | USD 13.9 |
| Day Range | USD 13.73 – 13.9 |
| 52-Week Range | USD 12.94 – 19.25 |
| Volume | 22,997 shares |
| Market Cap | $6.97B |
| Exchange | PNK |
Technical Analysis (SKHHY)
Nexqual's technical model rates SKHHY "NEUTRAL" based on 2 bullish and 3 bearish signals across 124 daily candles, as of June 10, 2026 at 03:50 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 53.05 (neutral) |
| vs SMA50 | Below (USD 13.91) |
| MACD | -0.09 (negative) |
Analyst Ratings (SKHHY)
Wall Street analysts rate SKHHY "None", per Nexqual as of June 10, 2026 at 03:50 UTC.
| Consensus Rating | None |
|---|
Earnings (SKHHY)
Source: Nexqual, June 10, 2026 at 03:50 UTC.
Financials & Fundamentals (SKHHY)
| Total Revenue | $10.42B |
|---|---|
| Revenue Growth (YoY) | +16.60% |
| Gross Margin | +32.84% |
| Operating Margin | +8.98% |
| Profit Margin | +5.18% |
| ROE | +6.63% |
| Debt / Equity | 68.22 |
| Current Ratio | 1.01 |
| Total Cash | $557.12M |
| Total Debt | $5.95B |
| Free Cash Flow | $597.78M |
Source: Nexqual, June 10, 2026 at 03:50 UTC.
Financial Health Score (SKHHY)
Nexqual rates SKHHY's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 03:50 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 33%, operating 9% |
| Balance Sheet | Solid — $557M cash vs $5.95B debt |
| Cash Flow | Solid — FCF $598M, 6% margin |
| Efficiency | Mixed — ROE 7%, ROA 3.8% |
Ownership (SKHHY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.01% |
| Shares Outstanding | 494.24M |
| Float | 458.20M |
Source: Nexqual, June 10, 2026 at 03:50 UTC.
Leadership (SKHHY)
SKHHY is led by James Pacey Newcombe, MD, CEO & Executive Director, per Nexqual as of June 10, 2026 at 03:50 UTC.
| MD, CEO & Executive Director | James Pacey Newcombe |
|---|---|
| Finance Director, CFO & Executive Director | Christopher David Wilks B.Com., F.A.C.I.D., F.A.I.C.D. (age 67) |
| Group Chief Operating Officer | Evangelos Kotsopoulos |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SSMXY | Sysmex Corp. | USD 9.04 | ▼ 1.53% |
| SKHCF | Sonic Healthcare Ltd. | USD 14.58 | ▲ 21.5% |
| SAUHY | Straumann Holding AG | USD 11.95 | ▲ 2.4% |
| NNGRY | NN Group NV | USD 41.48 | ▲ 1.15% |
| CHEOY | CochLear Ltd. | USD 36.24 | ▲ 3.81% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:50 UTC. This page is informational and not investment advice.